A. Ali et al. / Bioorg. Med. Chem. Lett. 18 (2008) 252–255
255
highly active against C. felis. Several O-benzyloxime
ether derivatives were also active against R. sanguineus,
although their levels of activity were generally less than
the best O-alkyloxime ether TFMS compounds.
best balance of activity against these ectoparasites was
generally exhibited by O-alkyloxime ether derivatives.
Furthermore, O-benzyl- and O-aryloxime ether TFMS
derivatives often displayed high in vitro activity against
the endoparasite H. contortus. The best endectoparasiti-
cidal activity was shown by O-benzyl- and O-aryloxime
ether derivatives such as compounds 42 and 64, respec-
tively. Further research to explore the parasiticidal
activity associated with the 2-alkoxy- and 2-aryl-
oxyiminoalkyl TFMS template is ongoing.
A number of O-benzyloxime ether TFMS compounds
also displayed excellent activity against H. contortus
when screened in a high-throughput H. contortus larval
development assay.8 Many derivatives showed levels of
activity comparable to the commercial endoparasiticide
drug levamisole, although none was as potent as iver-
mectin. Good activity was obtained for ketoxime ethers
where R1 was a methyl or ethyl group and R3 consisted
of at least one electron-withdrawing group: for example,
compounds 42 and 51. Aldoxime ethers such as com-
pound 57 were also highly active in the nematode assay.
It is apparent from SAR that the optimal O-benzyl moiety
for activity against H. contortus was the 2,4-bis(trifluoro-
methyl)benzyl group. Significantly, the most active O-
benzyloxime derivative (compound 51, LD99 = 0.22 lM)
maintained activity against resistant strains of H. contor-
tus: LD99 = 0.53 lM for the benzimidazole- and levam-
isole-resistant Lawes strain and LD99 = 0.53 lM for the
avermectin-resistant CAVR strain. Furthermore, com-
pound 51 was active against the McMaster strains of
Ostertagia circumcinta, LD99 = 1.1 lM, and Trichostron-
gylus colubriformis, LD99 = 2.2 lM.
Supplementary data
Supplementary data associated with this article can be
References and notes
1. Rust, M. K.; Dryden, M. W. Annu. Rev. Entomol. 1997,
42, 451.
2. Sonenshine, D. E. Biology of Ticks; Oxford University:
New York, 1991, Vol. 1, and 1993; Vol. 2.
3. Moriello, K. A. Anim. Health Res. Rev. 2003, 4, 157.
4. Payne, P. A.; Dryden, M. W.; Smith, V.; Ridley, R. K.
Vet. Parasitol. 2001, 102, 331.
5. Mori, T.; Takada, Y.; Hatakoshi, M.; Matsuo, N. Biosci.
Biotechnol. Biochem. 2004, 68, 425, and references cited
therein.
To further probe SAR associated with the 2-alkoxyimi-
noalkyl TFMS template, the O-benzyl moiety was re-
placed with an O-aryl unit. This structural change
eliminates a potential site of metabolic and/or chemical
degradation. Thus, a set of O-aryloxime ethers 63–80
were prepared from the reaction of a 2-keto TFMS 3
with an O-aryloxyamine 4 (Scheme 1 and Table 2).10,11
A number of these derivatives gave high mortality in a
cat flea assay, with some displaying levels of activity
comparable to the best O-alkyloxime ether TFMS com-
pounds. The most active derivatives had R1 as a methyl,
ethyl or i-propyl group, and R3 as a mono- or di-halo
substituent: for example, compounds 68, 71, and 78.
Several O-aryloxime ether derivatives were also highly
active in the dog tick assay, although these compounds
had LD50 values significantly greater than permethrin.
In some cases an O-aryloxime ether derivative was
highly active against both ectoparasites: for example,
compound 71 (LC50 = 10 ng/cm2 for C. felis, and
LD50 = 1.3 lg/tick for R. sanguineus). In contrast, a 5-
trifluoromethyl TFMS derivative (compound 69) highly
active against C. felis was inactive against dog tick.
Many O-aryloxime ether derivatives also displayed good
activity when screened in a H. contortus larval assay: for
example, compound 74 (LD99 = 0.83 lM).
6. McCracken, R. O.; Carr, A. W.; Stillwell, W. H.;
Lipkowitz, K. B.; Boisvenue, R.; O’Doherty, G. O. P.;
Wickiser, D. I. Biochem. Pharm. 1993, 45, 1873.
7. C. felis and R. sanguineus assays were conducted by the
Centre for Entomological Research and Insecticide Tech-
nology, UNSW, Randwick, NSW, Australia, or by
Agrisearch Services Pty. Ltd, 50 Leewood Drive, Orange,
NSW, Australia. Representative in vitro C. felis and R.
sanguineus single-dose assays and LC50/LD50 measure-
ment protocols are described in Supplementary data.
8. Nematocide assays were conducted by Microbial Screen-
ing Technologies Pty. Ltd, Smithfield, NSW, Australia.
H. contortus LD99 values were determined using the larval
development assay described in Ref. 9.
9. Gill, J. H.; Redwing, J. M.; Van Wyk, J. A.; Lacey, E. Int.
J. Parasitol. 1995, 25, 463.
10. Meyer, A. G.; Winzenberg, K. N.; Sawutz, D. G.; Liepa,
A. J. US Pat. Appl. Publ. US 2006063841 A1, 2006; Chem.
Abstr. 2006, 144, 331134.
11. Representative procedures describing the preparation of 2-
alkoxy- and 2-aryloxyiminoalkyl TFMS compounds, and
O-alkyl-, O-benzyl-, and O-aryloxyamines are given in
Supplementary data.
12. Mitochondrial uncoupling activity is primarily a function
of acidity (pKa) and lipophilicity (logP), see: Terada, H.
Biochim. Biophys. Acta 1981, 639, 225.
In summary, a number of novel 2-alkoxy- and 2-aryl-
oxyiminoalkyl TFMS derivatives displayed excellent
in vitro activity against C. felis and R. sanguineus. The
13. The low C. felis mortality observed for compound 51
probably reflects measurement of mortality at 8 h rather
than 24 h.